Abu Dhabi advances precision medicine for Alzheimer’s disease patients through pharmacogenomics reports
Highlighting a first-of-its-kind initiative in the region, Abu Dhabi integrates genetic insights into pharmacogenomics reports (PGx) to enhance treatment outcomes for Alzheimer’s patients. Patients with Alzheimer’s disease who carry two copies of the APOE E4 may be more prone to experiencing severe side effects such as brain swelling or bleeding with certain newer therapies. The […]
Read More